The expression of SEMA3C is related to tumor progression, and it has been reported that SEMA3C is directly associated with the poor prognosis of lung cancer, breast cancer, gastric cancer, and ovarian cancer [29, 30]. Here, SEMA3C is linked to gastric cancer.